Optimizing prostate cancer diagnosis: combining imaging modalities for tailored treatment
- PMID: 40133440
- DOI: 10.1007/s00330-025-11551-y
Optimizing prostate cancer diagnosis: combining imaging modalities for tailored treatment
Conflict of interest statement
Compliance with ethical standards. Guarantor: The scientific guarantor of this publication is Laura Evangelista. Conflict of interest: The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article. Statistics and biometry: No complex statistical methods were necessary for this paper. Informed consent: Not applicable. Ethical approval: Not applicable. Study subjects or cohorts overlap: Not applicable. Methodology: Commentary
Comment on
-
Discordance between prostate MRI and PSMA-PET/CT: the next big challenge for primary prostate tumor assessment?Eur Radiol. 2025 Jul;35(7):4043-4054. doi: 10.1007/s00330-025-11358-x. Epub 2025 Jan 24. Eur Radiol. 2025. PMID: 39853335
References
-
- Woo S, Becker AS, Leithner D et al (2025) Discordance between prostate MRI and PSMA PET/CT: the next big challenge for primary prostate tumor assessment. Eur Radiol. https://doi.org/10.1007/s00330-025-11358-x
-
- Pokorny MR, de Rooij M, Duncan E et al (2014) Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies. Eur Urol 66:22–29 - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
